UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report: November 07, 2000
MAXICARE HEALTH PLANS, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-12024 95-
3615709
(State or other (Commission (IRS
Employer
jurisdiction of File Number)
Identification No.)
incorporation)
1149 South Broadway Street
Los Angeles, California
(Address of principal executive office)
90015
(Zip Code)
(213) 765-2000
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
<PAGE>
5. Other Events
The Company announced on November 3, 2000 the closing
of the previously announced sale of 8.1 million shares of its
common stock at $1.00 per share with certain qualified
institutional buyers and highly accredited institutional
investors.
<PAGE>
Item 7. Financial Statements and Exhibits.
(b) Exhibits.
99.1 1. Press Release dated November 3, 2000 announcing the
completion of the
private placement transaction.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities and
Exchange Act of 1934, the Registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly
authorized.
MAXICARE HEALTH PLANS, INC.
(Registrant)
Date: November 7, 2000 By:__ /s/ Richard A.
Link________
Chief Financial Officer
<PAGE>
